-
公开(公告)号：KR101438367B1
公开(公告)日：2014-09-05
申请号：KR1020070100233
申请日：2007-10-05
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61K36/258 , A61Q19/08
Abstract: 본 발명은 인삼 열매 추출물을 함유하는 피부 외용제 조성물에 관한 것으로서, 보다 상세하게는 인삼의 지상부 중에서 독특한 성분과 조성을 갖는 인삼 열매 추출물을 유효성분으로 함유함으로써 피부에서 콜라겐생성을 촉진하며, MMP-1 억제효과를 나타내고, 동시에 항산화 효과와 DNA 손상보호효과를 통한 피부 노화억제 및 주름개선 효과를 갖는 피부 외용제 조성물에 관한 것이다. 또한 본 발명에 의한 피부 외용제 조성물은 멜라닌생성을 억제하고 자외선에 의한 색소침착을 개선하는 효과를 통하여 피부 미백효과를 나타내며, 피부각질형성세포의 분화를 정상유도하고 유지시킴으로써 피부건조증상과 아토피증상을 개선시킬 수가 있었고, 피지분비를 조절하며 항염증효과를 통한 여드름 및 피부 트러블 개선에도 효과적이며, 피부 말초혈액순환 개선을 통하여 혈색을 좋게 하여 피부를 맑고 투명하게 해준다.
인삼 열매, 피부 노화, 주름개선, 미백, 혈색개선, 피부건조, 아토피, 피부 트러블, 피부 외용제 조성물-
公开(公告)号：KR1020140069908A
公开(公告)日：2014-06-10
申请号：KR1020120137769
申请日：2012-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P27/02
CPC classification number: A61K36/258 , A23L33/105 , A23V2002/00 , A23V2200/30 , A23V2250/2124 , Y10S514/912
Abstract: The present invention relates to a composition comprising a ginseng fruit extract as an active ingredient which provides overall health benefits of the eye by alleviating symptoms of eye fatigue, tightness, dryness, pain, and itching. The composition according to the present invention has an excellent effect of promoting eye health and can effectively alleviating fatigue of the eyes by comprising the extract of ginseng fruit.
Abstract translation: 本发明涉及包含人参果实提取物作为活性成分的组合物，其通过减轻眼睛疲劳，紧张，干燥，疼痛和瘙痒的症状来提供眼睛的整体健康益处。 根据本发明的组合物具有促进眼睛健康的优异效果，并且可以通过包含人参水果的提取物来有效地减轻眼睛的疲劳。
-
公开(公告)号：KR1020130141420A
公开(公告)日：2013-12-26
申请号：KR1020130155424
申请日：2013-12-13
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/00 , A61P29/00
Abstract: The present invention relates to a composition for promoting blood circulation including the ginseng fruit extract as an active ingredient, a composition for blood vessel anti-aging, a blood vessel inflammation therapeutic composition, an angiogenesis promoting composition, a composition for treating ischemic heart diseases,a composition for relieving and treating partial blood flow shortage, in particular, and to a composition which includes ginseng fruit extract as an active ingredient to promote the generation of NO, the survival of blood vessel endothelial cell, and to accelerate the vascularization of blood vessel through the portability increment of the blood vessel endothelial cell and blood vessel tube production. [Reference numerals] (AA) Untreated group;(BB) Comparative example 1 100ug/ml;(CC) Example 1 100ug/ml;(DD) Example 2 100ug/ml;(EE) Untreated group;(FF) Untreated group contrast intensity (compared to untreated group %);(GG) Comparative example 1;(HH) Example 1;(II) Example 2
Abstract translation: 本发明涉及一种用于促进血液循环的组合物，包括人参果实提取物作为活性成分，用于血管抗衰老的组合物，血管炎症治疗组合物，促血管生成组合物，用于治疗缺血性心脏病的组合物， 特别是用于缓解和治疗部分血流短缺的组合物，以及包含人参水果提取物作为活性成分的组合物，以促进NO的产生，血管内皮细胞的存活和加速血管的血管化 通过血管内皮细胞和血管管生产的可移植性增加。 （AA）未处理组;（BB）比较例1 100ug / ml;（CC）实施例1 100ug / ml;（DD）实施例2100μg/ ml;（EE）未处理组;（FF） 强度（与未处理组％相比）;（GG）比较例1;（HH）实施例1;（II）实施例2
-
-
公开(公告)号：KR1020130047932A
公开(公告)日：2013-05-09
申请号：KR1020110112764
申请日：2011-11-01
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol for suppressing aging is provided to enhance SIRT1 expression, to suppress MMP-9 expression and collagen decomposition, and to improve anti-wrinkling. CONSTITUTION: A composition for anti-aging contains 1-80wt% of syringaresinol as an active ingredient. Syringaresinol is contains in one or more extracts selected from a lindseed extract, a Phellodendri cortex extract, an Acanthopanacis cortex extract, a sesame extract, and a ginseng fruit extract. Syringaresinol is prepared using one or more selected from the group consisting of water, an organic solvent, and a mixture thereof. The composition promotes SIRT1(sirtuin 1) expression.
Abstract translation: 目的：提供含有用于抑制老化的丁香精醇的组合物，以增强SIRT1表达，抑制MMP-9的表达和胶原分解，并改善抗皱纹。 构成：抗老化组合物含有1-80重量％的作为活性成分的丁香麻醇。 吩噻嗪醇含有一种或多种提取物，其选自泻药提取物，黄柏提取物，刺五加皮质提取物，芝麻提取物和人参果实提取物。 使用一种或多种选自水，有机溶剂及其混合物的组合制备吸入辛胺醇。 该组合物促进SIRT1（sirtuin 1）表达。
-
Patent Agency Ranking
公开(公告)号：KR1020130047792A
公开(公告)日：2013-05-09
申请号：KR1020110110484
申请日：2011-10-27
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol as an active ingredient is provided to suppress melanogenesis and tyrosinase activity, and to ensure anti-oxidation and skin whitening. CONSTITUTION: A composition for skin whitening contains 0.001-20wt% of syringaresinol as an active ingredient. The composition enhances the brightness and uniformity of skin color. The composition treats hyperpigmentation. The hyperpigmentation includes melasma, seborrheic keratosis, freckle, nevus, and dark circle. Syringaresinol is contained in an extract selected among a lindseed extract, a Phellodendri cortex extract, an Acanthopanacis cortex extract, a sesame extract, and a ginseng fruit extract. The composition is used for removing dead skin cells and promotes dead skin cell turn over. [Reference numerals] (AA) Syringaresinol
Abstract translation: 目的：提供含有作为活性成分的丁香红醇的组合物，以抑制黑素生成和酪氨酸酶活性，并确保抗氧化和皮肤美白。 构成：用于皮肤美白的组合物含有0.001-20重量％的作为活性成分的丁二腈。 该组合物增强了肤色的亮度和均匀性。 该组合物治疗色素沉着过度。 色素沉着过多包括黑斑病，脂溢性角化病，雀斑，痣和黑眼圈。 戒毒素包含在选自泻药提取物，黄柏提取物，刺五加皮质提取物，芝麻提取物和人参果实提取物中的提取物中。 该组合物用于去除死皮细胞并促进死皮细胞翻转。 （标号）（AA）异丙肾上腺素
-
公开(公告)号：KR1020130046115A
公开(公告)日：2013-05-07
申请号：KR1020110110486
申请日：2011-10-27
Applicant: (주)아모레퍼시픽
CPC classification number: A61K31/34 , A23L33/105 , A23V2002/00 , A61K9/0014 , A61K9/0053 , A61K9/0095 , A61K9/1652 , A61K9/2059 , A61K36/00 , A61K36/185 , A61K36/254 , A61K36/258 , A61K36/55 , A61K36/756 , A23V2200/302 , A23V2200/326 , A23V2250/21
Abstract: PURPOSE: A composition containing syringaresinol for suppressing aging of blood vessels is provided to enhance SIRT 1 expression in vascular cells, to activate telomerase, and to suppress aging of blood vessel. CONSTITUTION: A composition for suppressing aging of blood vessel contains syringaresinol as an active ingredient. The composition is used for preventing or treating cardiovascular diseases such as cerebral infarction, cerebral hemorrhage, ischemic heart disease, myocardial infarction, and arteriosclerosis. Syringaresinol is contained in extracts selected among a linseed extract, a Phellodendri cortex extract, an Acanthopanax sessiliflorum extract, a sesame extract, and a ginseng fruit extract. [Reference numerals] (AA) Syringaresinol
Abstract translation: 目的：提供一种含有抑制血管老化的丁香ares酚的组合物，以增强血管细胞中SIRT 1的表达，激活端粒酶，抑制血管老化。 构成：用于抑制血管衰老的组合物含有作为活性成分的丁香腈。 该组合物用于预防或治疗心脑血管疾病如脑梗塞，脑出血，缺血性心脏病，心肌梗死和动脉硬化。 提取物中含有亚麻子提取物，黄柏提取物，刺五加提取物，芝麻提取物和人参果实提取物中的提取物。 （标号）（AA）异丙肾上腺素
-
公开(公告)号：KR1020130045631A
公开(公告)日：2013-05-06
申请号：KR1020110109961
申请日：2011-10-26
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol for treating immune diseases is provided to promote SIRT 1 expression in immunocytes and differentiation to type 2 immunocytes, and to prevent or treat immune diseases. CONSTITUTION: A composition for preventing or treating immune diseases contains 1-80 wt% of syringaresinol as an active ingredient. The immune diseases include one or more among allergy, atopic dermatitis, hay fever, and rheumatoid arthritis. Syringaresinol is contained in one or more extracts selected among a linseed extract, a Phellodendri cortex extract, a sesame extract, and a ginseng fruit extract. [Reference numerals] (AA) MRNA of SIRT1 compared to a control group; (BB) 20uM syringaresinol; (CC) 50uM syringaresinol; (DD) 100uM syringaresinol
Abstract translation: 目的：提供一种含有用于治疗免疫疾病的丁香麻醇的组合物，用于促进免疫细胞中的SIRT1表达，分化为2型免疫细胞，并预防或治疗免疫疾病。 构成：用于预防或治疗免疫疾病的组合物含有1-80重量％的作为活性成分的丁香麻醇。 免疫疾病包括过敏，特应性皮炎，花粉症和类风湿性关节炎中的一种或多种。 苯丁酸钠含有选自亚麻子提取物，黄柏提取物，芝麻提取物和人参果实提取物中的一种或多种提取物。 [参考数字] SIRT1与对照组相比的（AA）MRNA; （BB）20uM syringaresinol; （CC）50uM syringaresinol; （DD）100uM syringaresinol
-
公开(公告)号：KR1020120133405A
公开(公告)日：2012-12-11
申请号：KR1020110052008
申请日：2011-05-31
Applicant: (주)아모레퍼시픽
IPC: A61K47/36 , A61K36/258 , A61K31/715
CPC classification number: A61K47/36 , A61K31/717 , A61K31/721 , A61K31/723 , A61K36/258
Abstract: PURPOSE: A ginseng composition containing a ginseng concentrate, water soluble polysaccharides, and a thickener is provided to ensure dissolubility and to be used in a food, drug, and cosmetic product. CONSTITUTION: A ginseng composition contains: 0.1-80 parts by weight of ginseng concentrate; 0.01-80 parts by weight of water soluble polysaccharides; and 0.01-10 parts by weight of thickener. The water soluble polysaccharides contain 0.01-80 parts by weight of maltodextrin and 1-80 parts by weight of indigestible matodextrin. The thickener is detran, gellan gum, rhamsan gum, welan gum, xanthan gum, or microfibrous cellulose. The viscosity of the composition is 450-550 cps.
Abstract translation: 目的：提供含有人参浓缩物，水溶性多糖和增稠剂的人参组合物，以确保溶解性并用于食品，药物和化妆品中。 组成：人参组合物含有：0.1-80重量份人参精矿; 0.01-80重量份水溶性多糖; 和0.01-10重量份的增稠剂。 水溶性多糖含有0.01-80重量份的麦芽糖糊精和1-80重量份的消化不良消化的木质纤维素。 增稠剂是脱水，结冷原胶，二恶唑胶，韦兰胶，黄原胶或微纤维纤维素。 组合物的粘度为450-550厘泊。
-
公开(公告)号：KR1020110078361A
公开(公告)日：2011-07-07
申请号：KR1020090135150
申请日：2009-12-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61K8/97 , A61Q5/00
CPC classification number: A61K36/258 , A61K8/97 , A61K2236/17 , A61Q5/00
Abstract: PURPOSE: A composition containing ginseng berry extract is provided to enhance MITF expression in melanocytes and to promote black hair growth. CONSTITUTION: A composition for preventing grey hair and vitiligo contains 0.001-30 weight% of ginseng berry extract as an active ingredient. A cosmetic composition for preventing grey hair contains cosmetically acceptable medium or substrate. The cosmetic composition is manufactured in the form of an emulsion, microemulsion, microcapsule, cream, skin, lotion, ointment, and spray.
Abstract translation: 目的：提供含有人参浆果提取物的组合物，以增强黑素细胞中的MITF表达，促进黑头发生长。 构成：防止灰白色和白癜风的组合物含有0.001-30重量％的人参浆果提取物作为活性成分。 用于防止灰发的化妆品组合物含有化妆品可接受的介质或底物。 化妆品组合物以乳液，微乳液，微胶囊，乳膏，皮肤，洗剂，软膏和喷雾剂的形式制造。
-
-
-
-
-
-
-
-
-
Search Results
145
records
(took 0.043 seconds)
